# INSPIRE: INnovative SABR for Prostate Cancer All IREland

> **NCT07552168** · PHASE2 · RECRUITING · sponsor: **Cancer Trials Ireland** · enrollment: 136 (estimated)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **RADIATION:** Next generation Stereotactic Ablative Radiotherapy (SABR)

## Key facts

- **NCT ID:** NCT07552168
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2030-09
- **Final completion:** 2034-11
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07552168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07552168, "INSPIRE: INnovative SABR for Prostate Cancer All IREland". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07552168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*